Stockreport

INSYS Therapeutics Signs Definitive License Agreement with Lunatus to Commercialize SUBSYS® (fentanyl sublingual spray) in the Middle East

INSYS THERAPEUTICS  (INSY) 
Last insys therapeutics earnings: 11/5 04:16 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.insysrx.com
PDF PHOENIX, Oct. 01, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the development, manufacture and commercialization of pharmaceutical ca [Read more]